In terms of revenue in 2014, the global market for hyaluronic acid was calculated to be USD 5.50 billion and is projected to reach USD 11.15 billion by 2022, growing at a CAGR of 9.7% from 2015 to 2022.
Hyaluronic acid is witnessing growth on the back of rising demand from cosmetics and medical applications. Moreover, growing incidence of ulcers, osteoarthritis and geriatric population is another major factor attributing towards market growth. However, other cost effective treatment present in the market and allergic reaction associated with it can restraint the market growth. Advancement in technology towards better health services is projected to fuel the market demand for hyaluronic acid.
Browse Full Report with Toc : http://www.credenceresearch.com/report/hyaluronic-acid-market
By product type, in 2014, five injection was the leading product type of hyaluronic acid and accounted for 40% share of the market. High usage is one of the major factor attributing towards the market growth. Single injection is forecasted to be the fastest growing market during the forecast period.
In 2014, dermal fillers was the largest application segment for hyaluronic acid and was calculated to be USD 2.04 billion. Vesicoureteral reflux is the fastest growing application segment of hyaluronic acid. Recent improvements are the factors driving the market growth.
Request Free Sample : http://www.credenceresearch.com/sample-request/57809
In 2014, North America was the largest market accounted for 37% share of the market pie. This is due to presence of geriatric population and high awareness among them regarding the different procedures. Asia Pacific is projected to be the fastest growing market during the forecast period. The market is projected to grow at a CAGR of 10.1% during the forecast period. Rapidly improving health care industry and rising awareness among the growing population are the factors attributing towards the growth. RoW is another lucrative market due to increasing awareness about the use and affects for hyaluronic acid.
Some of the major players present in this market are Salix Pharmaceuticals, Ferring Pharmaceuticals Inc., Anika Therapeutics Inc., and Allergan Inc among others.
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States